Protein engineering of Bacillus megaterium CYP102
- 15 May 2001
- journal article
- research article
- Published by Wiley in European Journal of Biochemistry
- Vol. 268 (10) , 3117-3125
- https://doi.org/10.1046/j.1432-1327.2001.02212.x
Abstract
Cytochrome P450 (CYP) enzymes are involved in activating the carcinogenicity of polycyclic aromatic hydrocarbons (PAHs) in mammals, but they are also utilized by microorganisms for the degradation of these hazardous environmental contaminants. Wild-type CYP102 (P450BM-3) from Bacillus megaterium has low activity for the oxidation of the PAHs phenanthrene, fluoranthene and pyrene. The double hydrophobic substitution R47L/Y51F at the entrance of the substrate access channel increased the PAH oxidation activity by up to 40-fold. Combining these mutations with the active site mutations F87A and A264G lead to order of magnitude increases in activity. Both these mutations increased the NADPH turnover rate, but the A264G mutation increased the coupling efficiency while the F87A mutation had dominant effects in product selectivity. Fast NADPH oxidation rates were observed (2250 min−1 for the R47L/Y51F/F87A mutant with phenanthrene) but the coupling efficiencies were relatively low (< 13%), resulting in a highest substrate oxidation rate of 110 min−1 for fluoranthene oxidation by the R47L/Y51F/A264G mutant. Mutation of M354 and L437 inside the substrate access channel reduced PAH oxidation activity. The PAHs were oxidized to a mixture of phenols and quinones. Notably mutants containing the A264G mutation showed some similarity to mammalian CYP enzymes in that some 9,10-phenanthrenequinone, the K-region oxidation product from phenanthrene, was formed. The results suggest that CYP102 mutants could be useful models for PAH oxidation by mammalian CYP enzymes, and also potentially for the preparation of novel PAH bioremediation systems.Keywords
This publication has 39 references indexed in Scilit:
- High-resolution crystal structure of cytochrome P450camPublished by Elsevier ,2005
- Cytochrome P450105D1 (CYP105D1) from Streptomyces griseus: Heterologous Expression, Activity, and Activation Effects of Multiple XenobioticsBiochemical and Biophysical Research Communications, 1999
- Roles of key active-site residues in flavocytochrome P450 BM3Biochemical Journal, 1999
- An unusual matrix of stereocomplementarity in the hydroxylation of monohydroxy fatty acids catalysed by cytochrome P450 from Bacillus megaterium with potential application in biotransformationsChemical Communications, 1999
- Production Of Alkanedioic Acids By Cytochrome P450Bm-3Monooxygenase: Oxidation Of 16-Hydroxyhexadecanoic Acid To Hexadecane-1, 16-Dioic AcidBiocatalysis and Biotransformation, 1999
- The structure of the cytochrome p450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acidNature Structural & Molecular Biology, 1997
- The role of Thr268 in oxygen activation of cytochrome P450BM-3Biochemistry, 1995
- Crystal Structure of Hemoprotein Domain of P450BM-3, a Prototype for Microsomal P450'sScience, 1993
- Microbial metabolism of pyreneChemico-Biological Interactions, 1986
- ω-1, ω-2 and ω-3 Hydroxylation of long-chain fatty acids, amides and alcohols by a soluble enzyme system from Bacillus megatyeriumBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1975